The ethics of psychedelic research in disorders of consciousness
Andrew Peterson, Enzo Tagliazucchi, Charles Weijer
Neuroscience of Consciousness 2019 DOI: 10.1093/nc/niz013 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Theoretical or philosophical paper Peer reviewed |
|---|---|
| Citations | 25 |
| Key points | Argues that the Value-Validity Framework and Component Analysis are applicable ethical tools for evaluating psychedelic research with disorders of consciousness patients. |
Abstract
This article provides an ethical analysis of psychedelic research involving disorders of consciousness patients. We apply two internationally accepted approaches for analyzing the ethics of human research, the Value-Validity Framework and Component Analysis, to a research program recently proposed by Scott and Carhart-Harris. We focus on Scott and Carhart-Harris's proposal, but the ethical frameworks outlined are applicable to other novel research protocols in the science of consciousness.
Citations in the library
Cited by 19
- Ethics and ego dissolution: the case of psilocybin Journal of Medical Ethics May 27, 2020
- Psychedelics, entropic brain theory, and the taxonomy of conscious states: a summary of debates and perspectives. Neuroscience of Consciousness 2023
- Depression as a Disorder of Consciousness The British Journal for the Philosophy of Science August 16, 2021
- Whole brain modelling for simulating pharmacological interventions on patients with disorders of consciousness. Communications Biology September 19, 2024
- Psychedelics and disorders of consciousness: the current landscape and the path forward. Neuroscience of Consciousness June 15, 2024
and 14 more in the library
Cites 11
- Psilocybin with psychological support for treatment-resistant depression: an open-label feasibility study. The Lancet Psychiatry May 17, 2016
- A Theoretically Based Index of Consciousness Independent of Sensory Processing and Behavior Science Translational Medicine August 14, 2013
- Human hallucinogen research: guidelines for safety. Journal of Psychopharmacology July 1, 2008
- Psychedelics Promote Structural and Functional Neural Plasticity Cell Reports June 1, 2018
- Psilocybin with psychological support for treatment-resistant depression: six-month follow-up. Psychopharmacology November 8, 2017
and 6 more in the library